/ APVO
/ Market Analysis
Why did Aptevo Therapeutics Shares Skyrocket in Premarket Trading Today?
Aptevo Therapeutics stock soared 123% in premarket trading following promising Phase 1b/2 trial results.
June 18, 2025Aptevo Therapeutics stock soared 123% in premarket trading following promising Phase 1b/2 trial results.
June 18, 2025